Polypharmacy - is There a Cure for Drug Therapy Problems?

Overview

Journal Croat Med J

Specialty General Medicine

Date 2023 Sep 1

PMID 37654043

Authors

Helena Orehovacki

Andrea Brajkovic

Lucija Ana Bicanic

Iva Mucalo

Affiliations

Soon will be listed here.

Citing Articles

Bridging gaps in medication therapy management at community health centers: A mixed-methods study on patient perceptions and pharmacists' preparedness.

Yasin N, Kurniawati F, Ridhayani F Explor Res Clin Soc Pharm. 2025; 17():100554.

PMID: 39811096 PMC: 11732552. DOI: 10.1016/j.rcsop.2024.100554.

Drug therapy problems among hospitalized patients with cardiovascular disease.

Niriayo Y, Kifle R, Asgedom S, Gidey K BMC Cardiovasc Disord. 2024; 24(1):50.

PMID: 38221638 PMC: 10788969. DOI: 10.1186/s12872-024-03710-8.

References

Oliveira D, Brummel A, Miller D . Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010; 16(3):185-95. PMC: 10437567. DOI: 10.18553/jmcp.2010.16.3.185. View

Babirye M, Yadesa T, Tamukong R, Obwoya P . Prevalence and factors associated with drug therapy problems among hypertensive patients at hypertension clinic of Mbarara Regional Referral Hospital, Uganda: a |cross-sectional study. Ther Adv Cardiovasc Dis. 2023; 17:17539447231160319. PMC: 10101216. DOI: 10.1177/17539447231160319. View

Benson M, Murphy D, Hall L, Vande Kamp P, Cook D . Medication management for complex patients in primary care: application of a remote, asynchronous clinical pharmacist model. Postgrad Med. 2021; 133(7):784-790. DOI: 10.1080/00325481.2021.1934492. View

Obreli Neto P, Marusic S, de Lyra Junior D, Pilger D, Cruciol-Souza J, Gaeti W . Effect of a 36-month pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients. J Pharm Pharm Sci. 2011; 14(2):249-63. DOI: 10.18433/j3259q. View

Nundy S, Cooper L, Mate K . The Quintuple Aim for Health Care Improvement: A New Imperative to Advance Health Equity. JAMA. 2022; 327(6):521-522. DOI: 10.1001/jama.2021.25181. View

Mucalo I, Brajkovic A, Strgacic M, Ramalho-de-Oliveira D, Ribaric E, Bobinac A . Budget Impact Analysis of Pharmacist-Led Medication Management in Cardiovascular and Type 2 Diabetic Patients. Healthcare (Basel). 2022; 10(4). PMC: 9027851. DOI: 10.3390/healthcare10040722. View

Brajkovic A, Mucalo I, Vidovic T, Gonzaga M, Nascimento D, Balenovic A . Implementation of medication management services at the primary healthcare level - a pilot study. Acta Pharm. 2019; 69(4):585-606. DOI: 10.2478/acph-2019-0055. View

Zillich A, Jaynes H, Bex S, Boldt A, Walston C, Ramsey D . Evaluation of pharmacist care for hypertension in the Veterans Affairs patient-centered medical home: a retrospective case-control study. Am J Med. 2014; 128(5):539.e1-6. DOI: 10.1016/j.amjmed.2014.11.027. View

Berwick D, Nolan T, Whittington J . The triple aim: care, health, and cost. Health Aff (Millwood). 2008; 27(3):759-69. DOI: 10.1377/hlthaff.27.3.759. View

10.

Santos B, do Nascimento M, Oliveira G, Nascimento Y, Mambrini J, Cid A . Clinical Impact of a Comprehensive Medication Management Service in Primary Health Care. J Pharm Pract. 2019; 34(2):265-271. DOI: 10.1177/0897190019866309. View

11.

Gnjidic D, Hilmer S, Blyth F, Naganathan V, Waite L, Seibel M . Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012; 65(9):989-95. DOI: 10.1016/j.jclinepi.2012.02.018. View

12.

Isetts B, Schondelmeyer S, Heaton A, Wadd W, Hardie N, Artz M . Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life. Res Social Adm Pharm. 2006; 2(1):129-42. DOI: 10.1016/j.sapharm.2005.12.002. View

13.

Planas L, Crosby K, Mitchell K, Farmer K . Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc (2003). 2009; 49(2):164-70. DOI: 10.1331/JAPhA.2009.08164. View

14.

Mourao A, Ferreira W, Martins M, Moreira Reis A, Carrillo M, Guimaraes A . Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial. Int J Clin Pharm. 2012; 35(1):79-86. DOI: 10.1007/s11096-012-9710-7. View

15.

Charlesworth C, Smit E, Lee D, Alramadhan F, Odden M . Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988-2010. J Gerontol A Biol Sci Med Sci. 2015; 70(8):989-95. PMC: 4573668. DOI: 10.1093/gerona/glv013. View

16.

Detoni K, Oliveira I, Nascimento M, Caux T, Alves M, Ramalho-de-Oliveira D . Impact of a medication therapy management service on the clinical status of patients with chronic obstructive pulmonary disease. Int J Clin Pharm. 2016; 39(1):95-103. DOI: 10.1007/s11096-016-0402-6. View

17.

Watanabe J, McInnis T, Hirsch J . Cost of Prescription Drug-Related Morbidity and Mortality. Ann Pharmacother. 2018; 52(9):829-837. DOI: 10.1177/1060028018765159. View

18.

McBane S, Dopp A, Abe A, Benavides S, Chester E, Dixon D . Collaborative drug therapy management and comprehensive medication management-2015. Pharmacotherapy. 2015; 35(4):e39-50. DOI: 10.1002/phar.1563. View

19.

Brummel A, Soliman A, Carlson A, Oliveira D . Optimal diabetes care outcomes following face-to-face medication therapy management services. Popul Health Manag. 2012; 16(1):28-34. DOI: 10.1089/pop.2012.0023. View

20.

Brajkovic A, Bosnar L, do Nascimento M, Prkacin I, Balenovic A, Oliveira D . Healthcare Utilisation and Clinical Outcomes in Older Cardiovascular Patients Receiving Comprehensive Medication Management Services: A Nonrandomised Clinical Study. Int J Environ Res Public Health. 2022; 19(5). PMC: 8910212. DOI: 10.3390/ijerph19052781. View